Under this agreement, LubioScience will exclusively distribute Mabtech’s portfolio of ELISA, EYRAplex, ELISpot and FluoroSpot assays, as well as associated antibodies and reagents. Customers will benefit from local availability, application-focused technical support and efficient logistics, while maintaining access to Mabtech’s well-established assay quality and reproducibility.

Mabtech is widely known for its focus on immune monitoring technologies that enable sensitive and reliable detection of cytokines and other biomarkers. By partnering with LubioScience, the company aims to further strengthen its presence in key European markets and support scientists working in immunology, oncology, infectious diseases and vaccine research.

“We are excited to partner with LubioScience to make Mabtech’s immune-monitoring solutions even more accessible to the Swiss life-science community,” said Carles Solà, Head of Sales EMEA and APAC at Mabtech AB. “With LubioScience’s strong local scientific support and efficient logistics, researchers can move faster from experimental design to robust data, while relying on the quality and reproducibility Mabtech is known for.”

LubioScience brings long-standing experience in life science distribution and a strong customer-oriented approach, with dedicated specialists supporting laboratories from experimental design to implementation. The partnership reflects both companies’ commitment to advancing life science research through high-quality products and close collaboration with the scientific community.